In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo (Q57395959)
Jump to navigation
Jump to search
scientific article published on 01 December 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo |
scientific article published on 01 December 2002 |
Statements
In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo (English)
Gunter Schuch
Marcelle Machluf
Georg Bartsch
Masashi Nomi
Henri Richard
1 December 2002